Literature DB >> 3901851

The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome.

B Safai, K G Johnson, P L Myskowski, B Koziner, S Y Yang, S Cunningham-Rundles, J H Godbold, B Dupont.   

Abstract

Kaposi's sarcoma is a multifocal systemic neoplasm histologically characterized by proliferating fibroblastic and microvascular elements. Initial signs include macules, papules, or nodules on the skin or mucosal surface. Lesions are frequently found on the trunk, arms, and head and neck. In general, sites of involvement and tumor load do not correlate with prognosis. A general decrease in the functional capacities of T and B cells is found in most patients. Kaposi's sarcoma is reported as the initial manifestation of the acquired immunodeficiency syndrome (AIDS) in approximately 30% of cases. Most cases are in men, although it has been reported in all risk groups. Kaposi's sarcoma in AIDS is more frequent among whites and homosexuals than blacks and intravenous drug abusers. Overall mortality is approximately 41%, with over 60% of patients alive at 1 year and 50% at 22 months. Overall survival is 18 months; however, some patients who have had the disease for 3 to 4 years are still doing well.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Behavior; Cancer; Developed Countries; Developing Countries; Diseases; Drugs; Ethnic Groups; Hiv Infections; Homosexuals; Mortality; Neoplasms; North America; Northern America; Sex Behavior; United States; Viral Diseases

Mesh:

Substances:

Year:  1985        PMID: 3901851     DOI: 10.7326/0003-4819-103-5-744

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  36 in total

1.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

3.  UV activation of human immunodeficiency virus gene expression in transgenic mice.

Authors:  J Vogel; M Cepeda; E Tschachler; L A Napolitano; G Jay
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986.

Authors:  J S Dummer; S Erb; M K Breinig; M Ho; C R Rinaldo; P Gupta; M V Ragni; A Tzakis; L Makowka; D Van Thiel
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

5.  Prognostic factors in acquired immunodeficiency syndrome.

Authors:  J D Wenger; C C Whalen; M M Lederman; T J Spech; J T Carey; J W Tomford; C S Landefeld
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

6.  Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Authors:  F Samaniego; P D Markham; R Gendelman; Y Watanabe; V Kao; K Kowalski; J A Sonnabend; A Pintus; R C Gallo; B Ensoli
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

7.  Hepatosplenic AIDS-related Kaposi's sarcoma.

Authors:  C Valls; C Cañas; L G Turell; X Pruna
Journal:  Gastrointest Radiol       Date:  1991

8.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Authors:  G Barillari; R Gendelman; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.

Authors:  Qi Ma; Lucas E Cavallin; Howard J Leung; Chiara Chiozzini; Pascal J Goldschmidt-Clermont; Enrique A Mesri
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

10.  The effects of immune status and race on health service use among people with HIV disease.

Authors:  J D Piette; V Mor; K Mayer; S Zierler; T Wachtel
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.